Receiving an updated 2024-2025 COVID-19 vaccine can restore and enhance protection against the virus variants currently responsible for most infections and hospitalizations in the United States.
Most people need only one dose of the flu vaccine each season.
“Our top recommendation for protecting yourself and your loved ones from respiratory illness is to get vaccinated,” said Mandy Cohen, M.D., M.P.H. “Make a plan now for you and your family to get both updated flu and COVID vaccines this fall, ahead of the respiratory virus season.”
https://www.cdc.gov/media/releases/2024/...tions.html
The updated vaccines are not expected to prevent all cases of COVID, including those causing mild illness; rather, their aim is to reduce severe illness, hospitalization, and death from infection.
The FDA is calling the newest shots “updated vaccines” in anticipation of needing to provide updated formulas annually, similar to the flu shot, which changes each year.
People 5 years and older may get one dose of the updated vaccine at least two months after the last dose of any previous COVID vaccine.
Babies and young children usually need more doses than older children and teens. Anyone who recently had COVID may consider delaying their vaccine by 3 months.
People who are 65 or older should receive their second dose of the updated vaccine at least four months after the first dose.
Those in that age group who are immunocompromised should get the additional dose earlier—at least 2 months after the first one.
https://www.yalemedicine.org/news/update...gs-to-know
Need some advice why mRNA provaxxers still scared to update the latest mRNA jabs?
are chiu smarter than all health authorities combined lololololololol?
Pfizer launches cost-cutting drive as COVID sales fall
pharmaphorum
|2 days ago
Pfizer has said it will shed staff and cut its operating costs by around $3.5 billion, as it faces a shortfall in COVID-19 vaccine and treatment sales, with revenues now expected to be down around .
Insiders At Moderna Sold US$3.3m In Stock, Alluding To Potential Weakness
YAHOO!Finance
|5 days ago
Over the past year, many Moderna, Inc. ( NASDAQ:MRNA ) insiders sold a significant stake in the company which may
Moderna shares hold rating as FDA approves new COVID-19 vaccine
Investing
|8 days ago
The analyst from Brookline Capital Markets anticipates that Moderna's COVID-19 vaccine sales will include approximately 15.9 million doses in the United States and 19.1 million doses internationally.
Moderna reins in 2024 sales forecast, expects very low EU vaccine revenue
health.economictimes.indiatimes
|29 days ago
London: Moderna on Thursday cut its 2024 sales forecast for COVID-19 and respiratory syncytial virus vaccines by up to 25 per cent, or $1 billion, as it expects very low sales to the EU ..